(ML) Compagnie Generale des - Overview
Stock: Tires, Maps, Services, Materials, Mobility
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.11% |
| Yield on Cost 5y | 5.59% |
| Yield CAGR 5y | -11.99% |
| Payout Consistency | 83.7% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 19.8% |
| Relative Tail Risk | -8.77% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.18 |
| Alpha | -0.66 |
| Character TTM | |
|---|---|
| Beta | 0.074 |
| Beta Downside | 0.075 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.18% |
| CAGR/Max DD | 0.27 |
Description: ML Compagnie Generale des December 19, 2025
Compagnie Générale des Établissements Michelin SCA (ticker ML) is a French-based, globally-active tire manufacturer founded in 1863 and headquartered in Clermont-Ferrand. The firm produces a full spectrum of tires for private vehicles (cars, motorcycles, bicycles, scooters) and for professional applications (freight, agriculture, construction, mining, civil-military, light rail, and aircraft), positioning itself across the entire mobility value chain.
Beyond tire sales, Michelin has expanded into mobility services (fleet-management platforms, navigation apps, travel guides), lifestyle accessories (car and bike gear, shoe soles, sports equipment), and high-tech materials (3D-metal printing, specialty rubbers, biosourced and recycled compounds). These non-tire segments now represent roughly 10-12 % of total revenue, providing a hedge against cyclical tire demand and aligning with sustainability trends in the automotive sector.
In FY 2023 Michelin reported €28.6 billion in revenue with an adjusted operating margin of 11.5 %, while raw-material price inflation and the shift toward electric-vehicle (EV) tires are key drivers of near-term earnings volatility. The company’s exposure to global automotive production cycles and to commodity price movements (natural rubber, synthetic polymers) makes macro-economic growth and input-cost trends critical levers for performance.
For a data-driven deep-dive into Michelin’s valuation metrics and scenario analysis, consider exploring the analyst tools on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income: 3.07b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 7.56 > 1.0 |
| NWC/Revenue: 13.72% < 20% (prev 14.22%; Δ -0.50% < -1%) |
| CFO/TA 0.24 > 3% & CFO 8.57b > Net Income 3.07b |
| Net Debt (4.40b) to EBITDA (7.62b): 0.58 < 3 |
| Current Ratio: 1.80 > 1.5 & < 3 |
| Outstanding Shares: last quarter (714.3m) vs 12m ago -0.75% < -2% |
| Gross Margin: 29.45% > 18% (prev 0.26%; Δ 2918 % > 0.5%) |
| Asset Turnover: 135.1% > 50% (prev 124.3%; Δ 10.81% > 0%) |
| Interest Coverage Ratio: 8.05 > 6 (EBITDA TTM 7.62b / Interest Expense TTM 537.0m) |
Altman Z'' 4.41
| A: 0.19 (Total Current Assets 14.78b - Total Current Liabilities 8.19b) / Total Assets 35.55b |
| B: 0.45 (Retained Earnings 16.02b / Total Assets 35.55b) |
| C: 0.12 (EBIT TTM 4.32b / Avg Total Assets 35.50b) |
| D: 0.86 (Book Value of Equity 15.40b / Total Liabilities 17.82b) |
| Altman-Z'' Score: 4.41 = AA |
Beneish M -3.27
| DSRI: 0.88 (Receivables 4.03b/4.18b, Revenue 47.97b/44.07b) |
| GMI: 0.89 (GM 29.45% / 26.27%) |
| AQI: 1.07 (AQ_t 0.22 / AQ_t-1 0.20) |
| SGI: 1.09 (Revenue 47.97b / 44.07b) |
| TATA: -0.15 (NI 3.07b - CFO 8.57b) / TA 35.55b) |
| Beneish M-Score: -3.27 (Cap -4..+1) = AA |
What is the price of ML shares?
Over the past week, the price has changed by +5.20%, over one month by +12.56%, over three months by +16.83% and over the past year by +3.85%.
Is ML a buy, sell or hold?
What are the forecasts/targets for the ML price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 36.2 | 9.8% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 35.2 | 6.6% |
ML Fundamental Data Overview February 03, 2026
P/E Trailing = 3.0713
P/E Forward = 9.0171
P/S = 0.8365
P/B = 1.2159
Revenue TTM = 47.97b EUR
EBIT TTM = 4.32b EUR
EBITDA TTM = 7.62b EUR
Long Term Debt = 4.89b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.84b EUR (from shortTermDebt, last quarter)
Debt = 7.52b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.40b EUR (from netDebt column, last quarter)
Enterprise Value = 26.84b EUR (22.43b + Debt 7.52b - CCE 3.12b)
Interest Coverage Ratio = 8.05 (Ebit TTM 4.32b / Interest Expense TTM 537.0m)
EV/FCF = 5.69x (Enterprise Value 26.84b / FCF TTM 4.72b)
FCF Yield = 17.57% (FCF TTM 4.72b / Enterprise Value 26.84b)
FCF Margin = 9.83% (FCF TTM 4.72b / Revenue TTM 47.97b)
Net Margin = 6.40% (Net Income TTM 3.07b / Revenue TTM 47.97b)
Gross Margin = 29.45% ((Revenue TTM 47.97b - Cost of Revenue TTM 33.84b) / Revenue TTM)
Gross Margin QoQ = 28.17% (prev 31.13%)
Tobins Q-Ratio = 0.75 (Enterprise Value 26.84b / Total Assets 35.55b)
Interest Expense / Debt = 1.74% (Interest Expense 131.0m / Debt 7.52b)
Taxrate = 26.96% (155.0m / 575.0m)
NOPAT = 3.16b (EBIT 4.32b * (1 - 26.96%))
Current Ratio = 1.80 (Total Current Assets 14.78b / Total Current Liabilities 8.19b)
Debt / Equity = 0.42 (Debt 7.52b / totalStockholderEquity, last quarter 17.72b)
Debt / EBITDA = 0.58 (Net Debt 4.40b / EBITDA 7.62b)
Debt / FCF = 0.93 (Net Debt 4.40b / FCF TTM 4.72b)
Total Stockholder Equity = 18.04b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.65% (Net Income 3.07b / Total Assets 35.55b)
RoE = 17.02% (Net Income TTM 3.07b / Total Stockholder Equity 18.04b)
RoCE = 18.86% (EBIT 4.32b / Capital Employed (Equity 18.04b + L.T.Debt 4.89b))
RoIC = 13.04% (NOPAT 3.16b / Invested Capital 24.22b)
WACC = 4.95% (E(22.43b)/V(29.96b) * Re(6.19%) + D(7.52b)/V(29.96b) * Rd(1.74%) * (1-Tc(0.27)))
Discount Rate = 6.19% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.36%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈3.64b ; Y1≈4.49b ; Y5≈7.64b
Fair Price DCF = 305.9 (EV 222.59b - Net Debt 4.40b = Equity 218.19b / Shares 713.3m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -21.01 | EPS CAGR: -64.01% | SUE: -0.75 | # QB: 0
Revenue Correlation: 23.76 | Revenue CAGR: -15.15% | SUE: 1.04 | # QB: 1
EPS next Year (2026-12-31): EPS=3.76 | Chg30d=-0.061 | Revisions Net=-6 | Growth EPS=+15.1% | Growth Revenue=+3.7%